Supplementary Figure S4 from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors

MLA

Ghazaleh Tabatabai, et al. Supplementary Figure S4 from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22479972.

APA

Ghazaleh Tabatabai, Carol Peña, Michael Jeffers, Eleni Lagkadinou, Charles Cai, Stefan Kaulfuss, Markus Wagner, Simon Langer, Susanne Reschke, Christine Rentzsch, Catya Munhoz, Isabelle Genvresse, Cristiana Roggia, Kamalesh K. Sankhala, Ulrik Lassen, Katharina Wenger, Michael C. Burger, Joachim P. Steinbach, Wolfgang Wick, … Antje Wick. (2023). Supplementary Figure S4 from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors. https://doi.org/10.1158/1078-0432.22479972

Chicago

Ghazaleh Tabatabai, Carol Peña, Michael Jeffers, Eleni Lagkadinou, Charles Cai, Stefan Kaulfuss, Markus Wagner, et al. 2023. “Supplementary Figure S4 from Phase I Assessment of Safety and Therapeutic Activity of BAY1436032 in Patients with IDH1-Mutant Solid Tumors,” March. doi:10.1158/1078-0432.22479972.